Medtronic Pacemaker communicate directly with patients’ smartphones and tablets

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE:MDT), today (October 8, 2020) announced the launch of the Azure™ pacemaker with BlueSync™ technology – India’s first and only pacemaker that can communicate directly with patients’ smartphones and tablets.

Azure™ with BlueSync™ Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring.

Are you interested to know more about it? If yes, here you go. The latest addition to Medtronic’s Cardiac Rhythm & Heart Failure portfolio in India, Azure is designed to accurately detect and reduce the likelihood of atrial fibrillation.

It offers improved longevity (up to 13.7 years), so patients potentially need fewer device replacements and allows patients to have MRI (magnetic resonance imaging) scans in either 1.5 or 3 Tesla (T) machines.

Azure features Medtronic-exclusive BlueSync technology, which enables automatic, secure wireless communication via Bluetooth Low Energy and remote monitoring via the Medtronic CareLink™ Network, providing more timely alerts of clinically relevant patient events that can be reviewed by a clinician at any time.

Security controls implemented and validated on BlueSync enabled devices include access restrictions to protect integrity of device functionality and end-to end encryption to protect patient data.

Atrial fibrillation (AF) is an irregular, rapid heart rate that may cause symptoms like heart palpitations, fatigue, and shortness of breath.

AF occurs when the upper chambers of the heart (atria) beat out of rhythm. As a result, blood is not pumped efficiently to the rest of the body, causing an unusually fast heart rate, quivering, or thumping sensations in the heart.